PATH is the leader in global health innovation. An international nonprofit organization, we save lives and improve health, especially among women and children. We accelerate innovation across five platforms—vaccines, drugs, diagnostics, devices, and system and service innovations—that harness our entrepreneurial insight, scientific and public health expertise, and passion for health equity. By mobilizing partners around the world, we take innovation to scale, working alongside countries primarily in Africa and Asia to tackle their greatest health needs. Together, we deliver measurable results that disrupt the cycle of poor health.

Mission Statement
PATH’s mission is to improve the health of people around the world by advancing technologies, strengthening systems, and encouraging healthy behaviors.
Donate Now
PO Box 900922 
(206) 285-3500 

Steve Davis 
President and CEO 


PATH Programs

Despite tremendous progress, millions of women and children living in the world’s poorest places still don’t have a fair chance for a healthy, productive life. PATH is ending the cycle of poverty and poor health by breaking through the bottlenecks that prevent health care, services, and technologies from reaching those who need them most. 

We work hand in hand with governments, communities, and partners—including nongovernmental organizations, the private sector, and United Nations agencies—to nurture bright ideas and move them all the way from smart concepts to lifesaving, widespread use. 

Our work addresses urgent health needs, with a focus on the world’s most vulnerable populations. This includes:
  • Solutions for emerging and epidemic diseases like HIV/AIDS, influenza, malaria, and tuberculosis. 
  • Development and delivery of lifesaving vaccines. 
  • Safer childbirth and healthier mothers and children. 
  • Health technologies, such as tools to diagnose disease, designed for the needs and limitations of low-resource settings. 
  • Better information, choices, and technologies for reproductive health, especially for vulnerable, low-income women. 
PATH’s work has been recognized by The Tech Museum of Innovation, Fast Company magazine, and Seattle Business magazine. We have been honored with the Conrad N. Hilton Humanitarian Prize. In 2012, PATH ranked among the top ten nongovernmental organizations in the Global Journal’s top 100 list and was recognized by Forbes as one of the United States’ most efficient charities. Charity Navigator, the largest independent evaluator of nonprofits in the United States, has awarded PATH four stars—the highest rating—for ten years in a row.

Recent Successes and Current Challenges

When innovation, tenacity, and the support of donors combine, we can transform global health. PATH’s affordable and sustainable solutions, together with our expertise in helping products and approaches move from bright ideas to widespread use, have led to landmark success.  

For example, we developed and introduced a vaccine for meningitis A—a devastating form of meningitis that sweeps across Africa in epidemic waves—through an unprecedented collaboration with the World Health Organization, African leaders, the private sector, and government agencies. Since the first immunization campaign in December 2010, more than 150 million people have received the vaccine—and to date, not a single vaccinated person has gotten meningitis A. The vaccine is providing new protection against death and disability, and stopping the crippling economic impact of the disease. 

Other breakthroughs include: 
  • A stable supply of malaria treatment.
    With a new semisynthetic version of the key ingredient in gold-standard medicines.
  • Historic protection for Asia’s children.
    With a World Health Organization stamp of approval for Japanese encephalitis vaccine.
  • Safe drinking water.
    For hundreds of thousands of low-income consumers in Africa and Asia.
  • A sure start for moms and babies.
    Making pregnancy and childbirth safer for 24.5 million people in India.
PATH’s work in more than 70 countries changed the lives of more than 205 million people in 2013. With support from our donors, we’re working toward a world where health is within reach for everyone.  

Our ability to be innovative and responsive to global health needs depends especially on support from individuals. In return, we provide a way for donors to have a powerful impact on the lives of people around the world.


By collaborating with diverse public- and private-sector partners, PATH provides appropriate health technologies designed for low resource environments such as more effective diagnostic technologies, solutions to malnutrition such as UltraRice®, simple innovations which continue to save birthing mothers and newborn babies, specialized syringes and needles, improved vaccines and vaccine delivery methods, and many more.

Proven Success
Established nearly 40 years ago, PATH now works in nearly 70 countries around the globe, and has more than 1,300 employees worldwide.  Its multidisciplinary staff range from scientists and experts in public health to policy and business strategists.  PATH is world-renowned for its innovative approach to improving health technologies.  It has been at the forefront of creating technologies that have fundamentally impacted countries around the globe.

Strong Leadership
PATH's executive team consists of its president and CEO, Steve Davis; four vice presidents; a chief strategy officer, human resources officer, financial officer, and operating officer; and general counsel.  The executive team is responsible for PATH's strategy, finances, and management - as well as PATH's overall success in achieving its mission.  The 11 members of PATH's board of directors are public health and business leaders from the United States and the countries it serves.  The board provides governance and fiduciary oversight, sets policy, and assesses PATH's overall performance.

In addition, PATH relies on an internationally recognized group of program leaders, including experts on specific diseases, immunization, maternal and child health, reproductive health, technology development, and vaccine development.

Financial Health
PATH has had consistent financial stability and continues to grow. Since the organization was established in 1977, its revenue has increased from less than $20 million to more than $300 million.  This growth has occurred across all of PATH's areas of focus, from emerging and epidemic diseases (for example, HIV, tuberculosis, and malaria) to new vaccines to innovative technologies for low-resource settings.

In 2012 PATH's total revenue was $312,819,000.  This funding comes from foundations, the US government and other governments, other nonprofit organizations, multilateral agencies such as the World Health Organization, individuals, and interest from investments.  More than 85 percent of its expenses go toward programs to improve the health of people around the world.

For ten years in a row, PATH has maintained Charity Navigator's highest possible ranking - four stars.  Private support from individuals, foundations, and corporations is critical to the organization's success.

(Evaluated by the Seattle International Foundation, a supporting organization of The Seattle Foundation)

Grant History with The Seattle Foundation:

Grants Awarded through The Seattle Foundation Grantmaking Program:

There are no recent grants awarded to this organization.


Similar Organizations

Questions or comments about this organization?
Contact us to learn more.